삼성바이오로직스

Controlling charge variants during bioprocessing is crucial for regulatory approval and clinical success. Our S-OptiCharge™ platform minimizes charged variants within samples while maximizing the main molecular form to ensure safe therapeutic effects by optimizing media, additives, and process parameters during a thorough screening procedure. Learn more about our newly launched upstream process platform: https://lnkd.in/gRMs_w6Z #SamsungBiologics #CDO #TherapeuticProtein #ChargeVariant

Explore how pharmaceutical companies are accelerating drug development by integrating technology innovations from adjacent industries. In this roundtable article, Heejeong Kim, Vice President and Head of Drug Substance Manufacturing, shares insights into the industry's adoption of digital twin technology to enhance operational excellence. https://lnkd.in/eAXysR5p #SamsungBiologics #DigitalTwin #innovation 

Our tailored services and proven expertise are specifically designed to meet the unique needs of your complex molecules. Discover how our commitment to operational excellence can enhance quality and accelerate your time to market. Read here: https://lnkd.in/dwFEUzQj #SamsungBiologics #Manufacturing #CDMO #ComplexMolecule

Check out the key highlights of October! This month, we signed a mega contract deal to support the manufacturing of advanced treatments and also introduced a high-concentration formulation development platform. Learn more about our latest business updates and commitment to innovation and quality. https://lnkd.in/gzjdWn9R #SamsungBiologics #DrivenForLife

From real-time monitoring to standardizing processes, Samsung Biologics is committed to minimizing downtime and delivering consistent product quality. Read our latest newsroom story to learn how we achieve seamless biopharmaceutical manufacturing through meticulous facility maintenance and optimized operations. Read more https://lnkd.in/g3sSbTGB #SamsungBiologics #cdmo #manufacturing #OperationalExcellence

As part of our continued commitment to technology innovation, Samsung Biologics leverages CDO platforms like S-AfuCHO™, S-OptiCharge™, and S-Tensify™ to enhance therapeutic efficacy and meet evolving industry needs. Get insights from this article on how we accelerate development, achieve the highest quality, and flexibly meet clients' goals. Read more: https://lnkd.in/gZqjSvbD #SamsungBiologics #drugdevelopment #cdmo

Ensuring viral safety in large-scale manufacturing requires a deep understanding of intricate factors that affect virus filter performance. In our latest article, we explore how shifts in air diffusion values impact virus clearance in multi-round housings as well as the key considerations for effective risk assessment. Read here: https://lnkd.in/eJ-a4wHt #SamsungBiologics #VirusFiltration #MSAT #Manufacturing #ScaleUp

While antibody-drug conjugates (ADC) are emerging as a promising class of anti-cancer treatment, access to effective therapeutic agents remains limited. In this webinar, we delve into the importance of choosing high-quality payloads in ADC development and how our novel payload technologies can support increased efficacy and safety. Register now: https://lnkd.in/e_NgyJXh #ADC #payloads #linker_technology #webinar 

We proactively stay ahead of industry expectations by delivering on our capacity expansion commitments down to the month. With a current total manufacturing capacity of 604 kL, we are continuously expanding our scope to grow with our clients and stay on track with their timelines: https://lnkd.in/gZgm3Wtr #SamsungBiologics #Commitment #OnTrack #Capacity

Recent innovations in intensified fed-batch (IFB) processing have led to substantial improvements in cell culture yields and scalability to support efficient biopharmaceutical production. Watch this webinar, where our upstream process development scientists discuss the latest advancements in IFB processing and how our S-Tensify™ platform ensures consistent quality and productivity. https://lnkd.in/gau_f2Wm #SamsungBiologics #drugdevelopment #celldensity #cellculture #CLD #FedBatch